Monetary Management Group’s Pfizer PFE Stock Holding History

Monetary Management Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.03M	Sell	36,700 -900	-2%	-$24K	0.25%	89
2025 Q4	$936K	Sell	37,600 -4,650	-11%	-$117K	0.22%	95
2025 Q3	$1.08M	Buy	42,250 +3,000	+8%	+$74K	0.25%	83
2025 Q2	$951K	Buy	39,250 +1,000	+3%	+$23.3K	0.23%	89
2025 Q1	$969K	Buy	38,250 +1,000	+3%	+$26.2K	0.26%	85
2024 Q4	$988K	Sell	37,250 -9,000	-19%	-$244K	0.26%	84
2024 Q3	$1.34M	Sell	46,250 -800	-2%	-$23.3K	0.34%	66
2024 Q2	$1.32M	Buy	47,050 +1,300	+3%	+$35.8K	0.35%	63
2024 Q1	$1.27M	Buy	45,750 +6,599	+17%	+$183K	0.35%	68
2023 Q4	$1.13M	Buy	39,151 +500	+1%	+$15.1K	0.35%	71
2023 Q3	$1.28M	Buy	38,651 +375	+1%	+$13.3K	0.43%	59
2023 Q2	$1.4M	Sell	38,276 -800	-2%	-$31.1K	0.43%	56
2023 Q1	$1.59M	Sell	39,076 -1,100	-3%	-$47.5K	0.47%	55
2022 Q4	$2.06M	Sell	40,176 -1,700	-4%	-$81.5K	0.64%	39
2022 Q3	$1.83M	Hold	41,876	–	–	0.6%	42
2022 Q2	$2.2M	Sell	41,876 -125	-0.3%	-$6.37K	0.69%	40
2022 Q1	$2.17M	Buy	42,001 +2,500	+6%	+$130K	0.58%	42
2021 Q4	$2.33M	Sell	39,501 -2,450	-6%	-$121K	0.58%	45
2021 Q3	$1.8M	Buy	41,951 +8,550	+26%	+$379K	0.5%	49
2021 Q2	$1.31M	Sell	33,401 -350	-1%	-$13.6K	0.39%	59
2021 Q1	$1.22M	Sell	33,751 -101	-0.3%	-$3.59K	0.38%	63
2020 Q4	$1.25M	Sell	33,852 -1,565	-4%	-$57.4K	0.41%	61
2020 Q3	$1.23M	Hold	35,417	–	–	0.44%	59
2020 Q2	$1.1M	Buy	35,417 +11,963	+51%	+$406K	0.42%	63
2020 Q1	$726K	Sell	23,454 -1,034	-4%	-$35.2K	0.32%	73
2019 Q4	$910K	Sell	24,488 -340	-1%	-$12.1K	0.33%	79
2019 Q3	$846K	Sell	24,828 -632	-2%	-$23K	0.32%	80
2019 Q2	$1.05M	Sell	25,460 -779	-3%	-$30.9K	0.4%	76
2019 Q1	$1.06M	Hold	26,239	–	–	0.42%	66
2018 Q4	$1.09M	Hold	26,239	–	–	0.49%	59
2018 Q3	$1.1M	Hold	26,239	–	–	0.42%	64
2018 Q2	$903K	Sell	26,239 -317	-1%	-$10.8K	0.37%	73
2018 Q1	$894K	Sell	26,556 -1,001	-4%	-$34.4K	0.37%	70
2017 Q4	$947K	Hold	27,557	–	–	0.38%	63
2017 Q3	$933K	Sell	27,557 -1,265	-4%	-$40.7K	0.39%	65
2017 Q2	$919K	Sell	28,822 -1,264	-4%	-$39.9K	0.38%	75
2017 Q1	$977K	Sell	30,086 -9,065	-23%	-$286K	0.42%	67
2016 Q4	$1.21M	Buy	39,151 +2,846	+8%	+$86.9K	0.56%	58
2016 Q3	$1.17M	Buy	36,305 +2,003	+6%	+$67K	0.54%	62
2016 Q2	$1.15M	Buy	34,302 +2,951	+9%	+$94.2K	0.53%	63
2016 Q1	$882K	Buy	31,351 +5,691	+22%	+$163K	0.43%	69
2015 Q4	$786K	Buy	25,660 +2,372	+10%	+$74.6K	0.38%	72
2015 Q3	$694K	Buy	23,288 +1,317	+6%	+$42.2K	0.35%	76
2015 Q2	$699K	Hold	21,971	–	–	0.32%	85
2015 Q1	$725K	Hold	21,971	–	–	0.32%	84
2014 Q4	$649K	Buy	21,971 +844	+4%	+$24.2K	0.29%	89
2014 Q3	$593K	Buy	21,127 +2,951	+16%	+$82.8K	0.27%	96
2014 Q2	$512K	Buy	18,176 +6,435	+55%	+$183K	0.24%	98
2014 Q1	$358K	Sell	11,741 -3,281	-22%	-$97.8K	0.17%	117
2013 Q4	$437K	Sell	15,022 -790	-5%	-$23K	0.2%	106
2013 Q3	$431K	Sell	15,812 -29,960	-65%	-$815K	0.23%	104
2013 Q2	$1.22M	Buy	+45,772	New	+$1.26M	0.67%	52

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Monetary Management Group's PFE Position: Q1 2026 in Review

Monetary Management Group reduced its Pfizer (PFE) stake by 2.4% in Q1 2026, selling an estimated $24K and leaving 36,700 shares worth $1.03M. The position accounts for 0.25% of the portfolio, ranked #89.

Monetary Management Group first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.33M in Q4 2021. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Monetary Management Group held 36,700 shares of Pfizer worth $1.03M as of Q1 2026.
Monetary Management Group sold 900 Pfizer shares in Q1 2026, an estimated $24K.
Pfizer made up 0.25% of Monetary Management Group's portfolio in Q1 2026, its #89 holding.
Monetary Management Group first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
Monetary Management Group's Pfizer position peaked at $2.33M in Q4 2021.
2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Monetary Management Group's 13F filing for Q1 2026, filed 13 May 2026.